Total Funding
51
65
Total FundingVenture - Series Unknown raised
Growth Score
-6 pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
61103
Newracle Science specializes in antibody treatment for neurodegenerative diseases.
About the Company
Neuracle Science is a developer of therapeutic antibody candidates aimed at healing the neurodegenerative brain by creating new synaptic connections. The company is focused on developing novel antibody drugs for neurological disorders. Presently, Neuracle Science is working on 'NS101,' a treatment for hearing loss, for which there are
currently no approved therapies. This includes the recent increase in paid-in capital, as well as the development of innovative diagnostic and therapeutic approaches for challenging diseases based on cutting-edge life science.
